Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the ribbon has been cut on the new Sacco System development site in Brisbane - Australia. Sacco System is a company with strong values, born over 150 years ago and still owned by the Verga Family, starting with the rennet production, nowadays is recognized worldwide as a biotech excellence in the production if enzyme, cultures, probiotics, postbiotics and LPB’s.
“Our Brisbane laboratories are designed to deliver early development for our fermentations. We aim to create industrial processes that are robust, reliable and compliant to regulation for a broad variety of microbes. Starting with our in-silico work we can bring all steps of fermentations to a volume of 30L to deliver the information necessary for our larger scale facilities to work effectively”, said Max Rossetto, Microbial Therapeutics Global Business Development Director.
“Being in Australia opening our development site for Next-gen microorganisms and live biotherapeutics is sensational and absolutely and totally inspirational per se. And working hard to make it became an excellence for Sacco System Group and for the Australian State is what we should be inspired to do in the next years!” said Viola Verga during her speech during the Grand Opening.
Australia was chosen as the site of our process development related to Next-gen microorganisms and live biotherapeutics for a number of reasons. It is easy set up a business in Australia, a modern, high quality business location with stable government, transparent regulations and which has deep and broad connections with Italy as mentioned by the Consul. This together with the presence of a cluster of microbiome related businesses and an impressive academic sector in Southern Queensland made Brisbane a natural choice for the first Sacco System site in the Asia Pacific region.